Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
The second episode of our ‘Enabling Successful Sites’ series features a discussion between Karen McIntyre (Vice President, Global Site Alliances), Xoli Belgrave (Sr. Director, Head of Clinical Trial Diversity and Inclusion), Jamie Langley (Executive Director, Parexel Academy) and Dr. Lovie Negrin, CEO and Founder of Randomize now on how we can empower and leverage sites with the tools and training they need to more successfully recruit diverse patient populations for their studies. They talk about the impact of not including diverse patient populations in studies is discussed, the need for sponsors and CROs to share their diversity, equity, and inclusion strategies with investigator sites, and soft skills site staff need to have for necessary conversations.
Episode 1: Site feasibility and study start-up challenges
Episode 3: Taking the complexity out of oncology clinical trials
Episode 4: Partnering with sites to improve patient recruitment and retention
Episode 5: Strategies for improving communication between sites, sponsors and CROs
Related Insights
Podcast
Enabling Successful Sites, Episode 3: Taking the complexity out of oncology clinical trials
Jun 28, 2024
Playbook
Insights from the 2022 R&D Innovation Survey
Feb 17, 2023
Blog
Making cell and gene therapy more accessible in the treatment of solid tumors
Jun 4, 2024
Blog
Best practices and lessons learned in a challenging IBD study
Jul 19, 2023
Article
Key strategies to mitigate the risks of asthma drug development
Jan 24, 2025
Article
Navigating the challenges of large, international Phase III breast cancer trials
Jul 29, 2025
Blog
Scientific Advances: Catalyst for Biotech Investment and Innovation in Clinical Development
Mar 12, 2024
Blog
How we can bring gene therapies to bear on diseases of aging
Jan 31, 2024
Blog
Reducing technology burdens: How sponsors and CROs can empower sites
Feb 7, 2024
Blog
How sponsors can make it easier for rare disease patients and families to participate in trials
Feb 13, 2024
Podcast
Rare endpoints: Delivering on unmet patient needs
May 7, 2024
Blog
Adapting the validation process for PROs for rare diseases and other diseases with large unmet need and/or rapid progression
Apr 23, 2024
Related Insights
Podcast
Enabling Successful Sites, Episode 3: Taking the complexity out of oncology clinical trials
Jun 28, 2024
Playbook
Insights from the 2022 R&D Innovation Survey
Feb 17, 2023
Blog
Making cell and gene therapy more accessible in the treatment of solid tumors
Jun 4, 2024
Blog
Best practices and lessons learned in a challenging IBD study
Jul 19, 2023
Article
Key strategies to mitigate the risks of asthma drug development
Jan 24, 2025
Article
Navigating the challenges of large, international Phase III breast cancer trials
Jul 29, 2025
Blog
Scientific Advances: Catalyst for Biotech Investment and Innovation in Clinical Development
Mar 12, 2024
Blog
How we can bring gene therapies to bear on diseases of aging
Jan 31, 2024
Blog
Reducing technology burdens: How sponsors and CROs can empower sites
Feb 7, 2024
Blog
How sponsors can make it easier for rare disease patients and families to participate in trials
Feb 13, 2024
Podcast
Rare endpoints: Delivering on unmet patient needs
May 7, 2024
Blog
Adapting the validation process for PROs for rare diseases and other diseases with large unmet need and/or rapid progression
Apr 23, 2024